CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sawano, A.
Right arrow Articles by Shibuya, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sawano, A.
Right arrow Articles by Shibuya, M.

Cell Growth & Differentiation, Vol 7, Issue 2 213-221, Copyright © 1996 by American Association of Cancer Research

ARTICLES

Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor

A Sawano, T Takahashi, S Yamaguchi, M Aonuma and M Shibuya
Department of Genetics, University of Tokyo, Japan.

Placenta Growth Factor (PIGF) is a new member of vascular endothelial growth factor (VEGF) family. Although VEGF binds Flt family Flt-1 and KDR/Flk-1 tyrosine kinases at high affinity for signal transduction, biological activities and the receptors of PIGF have not been extensively studied. Reverse transcription-PCR showed that PIGF-2, a subtype of PIGF-1 that bears a basic amino acid-rich domain, is more abundant than PIGF-1 and thus is the major subtype in human placenta. Using antibodies specific to PIGF-1 or -2 as markers, we obtained large amounts of PIGFs in the baculovirus expression system. PIGF-2 had growth-stimulatory activity on human umbilical vein endothelial cells and vascular permeability activity in the Miles assay at levels about 10-fold lower than those of VEGF. All PIGF-1 activities were lower than those of PIGF-2. Both PIGFs competed for the binding of 125I-labeled VEGF to Flt-1 receptor but not to KDR/Flk-1 expressed on NIH3T3 cells. Furthermore, 125I-labeled PIGF bound to Flt-1 at high affinity but not to KDR/Flk-1. Supporting the notion that PIGF can use only Flt-1 as a receptor, PIGF activated Flt-1 to autophosphorylate, whereas PIGF could not generate signals from KDR/Flk-1. These results indicate that Flt-1, but not KDR/Flk-1, is a receptor for PIGF, suggesting that the weak biological activities of PIGF are due to its use of only part of the available VEGF signaling. These mild characteristics of PIGF may be important for the appropriate development and maintenance of normal placental tissue.


This article has been cited by other articles:


Home page
 Cancer Res.Home page
M. Kerber, Y. Reiss, A. Wickersheim, M. Jugold, F. Kiessling, M. Heil, V. Tchaikovski, J. Waltenberger, M. Shibuya, K. H. Plate, et al.
Flt-1 Signaling in Macrophages Promotes Glioma Growth In vivo
Cancer Res., September 15, 2008; 68(18): 7342 - 7351.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
Y. Takei, T. Nemoto, P. Mu, T. Fujishima, T. Ishimoto, Y. Hayakawa, Y. Yuzawa, S. Matsuo, T. Muramatsu, and K. Kadomatsu
In vivo silencing of a molecular target by short interfering RNA electroporation: tumor vascularization correlates to delivery efficiency
Mol. Cancer Ther., January 1, 2008; 7(1): 211 - 221.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. Kunizaki, R. Hamamoto, F. P. Silva, K. Yamaguchi, T. Nagayasu, M. Shibuya, Y. Nakamura, and Y. Furukawa
The Lysine 831 of Vascular Endothelial Growth Factor Receptor 1 Is a Novel Target of Methylation by SMYD3
Cancer Res., November 15, 2007; 67(22): 10759 - 10765.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
R. Mohan
Eyes wide s-flt: clearly, avascular fidelity is a vascular endothelial growth factor family affair
Br. J. Ophthalmol., April 1, 2007; 91(4): 412 - 413.
[Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
H. Sano, K. Hosokawa, H. Kidoya, and N. Takakura
Negative Regulation of VEGF-Induced Vascular Leakage by Blockade of Angiotensin II Type 1 Receptor
Arterioscler. Thromb. Vasc. Biol., December 1, 2006; 26(12): 2673 - 2680.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
O. Nevo, N. Soleymanlou, Y. Wu, J. Xu, J. Kingdom, A. Many, S. Zamudio, and I. Caniggia
Increased expression of sFlt-1 in in vivo and in vitro models of human placental hypoxia is mediated by HIF-1
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2006; 291(4): R1085 - R1093.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. Nakamura, E. Taguchi, T. Miura, A. Yamamoto, K. Takahashi, F. Bichat, N. Guilbaud, K. Hasegawa, K. Kubo, Y. Fujiwara, et al.
KRN951, a Highly Potent Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases, Has Antitumor Activities and Affects Functional Vascular Properties.
Cancer Res., September 15, 2006; 66(18): 9134 - 9142.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. Murakami, S. Iwai, S. Hiratsuka, M. Yamauchi, K. Nakamura, Y. Iwakura, and M. Shibuya
Signaling of vascular endothelial growth factor receptor-1 tyrosine kinase promotes rheumatoid arthritis through activation of monocytes/macrophages
Blood, September 15, 2006; 108(6): 1849 - 1856.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
B Zhao, A Ma, J Cai, and M Boulton
VEGF-A regulates the expression of VEGF-C in human retinal pigment epithelial cells
Br. J. Ophthalmol., August 1, 2006; 90(8): 1052 - 1059.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
C. A. Glass, S. J. Harper, and D. O. Bates
The anti-angiogenic VEGF isoform VEGF165b transiently increases hydraulic conductivity, probably through VEGF receptor 1 in vivo
J. Physiol., April 1, 2006; 572(1): 243 - 257.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S. Niida, T. Kondo, S. Hiratsuka, S.-I. Hayashi, N. Amizuka, T. Noda, K. Ikeda, and M. Shibuya
VEGF receptor 1 signaling is essential for osteoclast development and bone marrow formation in colony-stimulating factor 1-deficient mice
PNAS, September 27, 2005; 102(39): 14016 - 14021.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
A. W. Mould, S. A. Greco, M. M. Cahill, I. D. Tonks, D. Bellomo, C. Patterson, A. Zournazi, A. Nash, P. Scotney, N. K. Hayward, et al.
Transgenic Overexpression of Vascular Endothelial Growth Factor-B Isoforms by Endothelial Cells Potentiates Postnatal Vessel Growth In Vivo and In Vitro
Circ. Res., September 16, 2005; 97(6): e60 - e70.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
B. Das, H. Yeger, R. Tsuchida, R. Torkin, M. F.W. Gee, P. S. Thorner, M. Shibuya, D. Malkin, and S. Baruchel
A Hypoxia-Driven Vascular Endothelial Growth Factor/Flt1 Autocrine Loop Interacts with Hypoxia-Inducible Factor-1{alpha} through Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase 1/2 Pathway in Neuroblastoma
Cancer Res., August 15, 2005; 65(16): 7267 - 7275.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
P. Nyberg, L. Xie, and R. Kalluri
Endogenous Inhibitors of Angiogenesis
Cancer Res., May 15, 2005; 65(10): 3967 - 3979.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
D.-G. Bae, T.-D. Kim, G. Li, W.-H. Yoon, and C.-B. Chae
Anti-Flt1 Peptide, a Vascular Endothelial Growth Factor Receptor 1-Specific Hexapeptide, Inhibits Tumor Growth and Metastasis
Clin. Cancer Res., April 1, 2005; 11(7): 2651 - 2661.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
K. Nakamura, A. Yamamoto, M. Kamishohara, K. Takahashi, E. Taguchi, T. Miura, K. Kubo, M. Shibuya, and T. Isoe
KRN633: A selective inhibitor of vascular endothelial growth factor receptor-2 tyrosine kinase that suppresses tumor angiogenesis and growth
Mol. Cancer Ther., December 1, 2004; 3(12): 1639 - 1649.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H. Takahashi, S. Hattori, A. Iwamatsu, H. Takizawa, and M. Shibuya
A Novel Snake Venom Vascular Endothelial Growth Factor (VEGF) Predominantly Induces Vascular Permeability through Preferential Signaling via VEGF Receptor-1
J. Biol. Chem., October 29, 2004; 279(44): 46304 - 46314.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
S. Rollin, C. Lemieux, R. Maliba, J. Favier, L. R. Villeneuve, B. G. Allen, S. Soker, N. G. Bazan, Y. Merhi, and M. G. Sirois
VEGF-mediated endothelial P-selectin translocation: role of VEGF receptors and endogenous PAF synthesis
Blood, May 15, 2004; 103(10): 3789 - 3797.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
C. Ye, C. Feng, S. Wang, K. Z. Q. Wang, N. Huang, X. Liu, Y. Lin, and M. Li
sFlt-1 Gene Therapy of Follicular Thyroid Carcinoma
Endocrinology, February 1, 2004; 145(2): 817 - 822.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
Y. Ueda, T. Yamagishi, K. Samata, H. Ikeya, N. Hirayama, H. Takashima, S. Nakaike, M. Tanaka, and I. Saiki
A novel low molecular weight antagonist of vascular endothelial growth factor receptor binding: VGA1155
Mol. Cancer Ther., November 1, 2003; 2(11): 1105 - 1111.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
N. Perelman, S. K. Selvaraj, S. Batra, L. R. Luck, A. Erdreich-Epstein, T. D. Coates, V. K. Kalra, and P. Malik
Placenta growth factor activates monocytes and correlates with sickle cell disease severity
Blood, August 15, 2003; 102(4): 1506 - 1514.
[Abstract] [Full Text] [PDF]

Home page
 Reproductive SciencesHome page
D. S. Torry, D. Mukherjea, J. Arroyo, and R. J. Torry
Expression and Function of Placenta Growth Factor: Implications for Abnormal Placentation
Reproductive Sciences, May 1, 2003; 10(4): 178 - 188.
[Abstract] [PDF]

Home page
 J. Biol. Chem.Home page
A. Kiba, N. Yabana, and M. Shibuya
A Set of Loop-1 and -3 Structures in the Novel Vascular Endothelial Growth Factor (VEGF) Family Member, VEGF-ENZ-7, Is Essential for the Activation of VEGFR-2 Signaling
J. Biol. Chem., April 4, 2003; 278(15): 13453 - 13461.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
D.C Felmeden, A.D Blann, and G.Y.H Lip
Angiogenesis: basic pathophysiology and implications for disease
Eur. Heart J., April 1, 2003; 24(7): 586 - 603.
[Full Text] [PDF]

Home page
 HypertensionHome page
B. Li, A. K. Ogasawara, R. Yang, W. Wei, G.-W. He, T. F. Zioncheck, S. Bunting, A. M. de Vos, and H. Jin
KDR (VEGF Receptor 2) Is the Major Mediator for the Hypotensive Effect of VEGF
Hypertension, June 1, 2002; 39(6): 1095 - 1100.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
T. Itokawa, H. Nokihara, Y. Nishioka, S. Sone, Y. Iwamoto, Y. Yamada, J. Cherrington, G. McMahon, M. Shibuya, M. Kuwano, et al.
Antiangiogenic Effect by SU5416 Is Partly Attributable to Inhibition of Flt-1 Receptor Signaling
Mol. Cancer Ther., March 1, 2002; 1(5): 295 - 302.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
M. Shimpo, U. Ikeda, Y. Maeda, M. Takahashi, H. Miyashita, H. Mizukami, M. Urabe, A. Kume, T. Takizawa, M. Shibuya, et al.
AAV-mediated VEGF gene transfer into skeletal muscle stimulates angiogenesis and improves blood flow in a rat hindlimb ischemia model
Cardiovasc Res, March 1, 2002; 53(4): 993 - 1001.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
K. Aase, G. von Euler, X. Li, A. Ponten, P. Thoren, R. Cao, Y. Cao, B. Olofsson, S. Gebre-Medhin, M. Pekny, et al.
Vascular Endothelial Growth Factor-B-Deficient Mice Display an Atrial Conduction Defect
Circulation, July 17, 2001; 104(3): 358 - 364.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
M. Kuzuya, M. A. Ramos, S. Kanda, T. Koike, T. Asai, K. Maeda, K. Shitara, M. Shibuya, and A. Iguchi
VEGF Protects Against Oxidized LDL Toxicity to Endothelial Cells by an Intracellular Glutathione-Dependent Mechanism Through the KDR Receptor
Arterioscler. Thromb. Vasc. Biol., May 1, 2001; 21(5): 765 - 770.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
R. Tordjman, S. Delaire, J. Plouet, S. Ting, P. Gaulard, S. Fichelson, P.-H. Romeo, and V. Lemarchandel
Erythroblasts are a source of angiogenic factors
Blood, April 1, 2001; 97(7): 1968 - 1974.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Hiratsuka, Y. Maru, A. Okada, M. Seiki, T. Noda, and M. Shibuya
Involvement of Flt-1 Tyrosine Kinase (Vascular Endothelial Growth Factor Receptor-1) in Pathological Angiogenesis
Cancer Res., February 1, 2001; 61(3): 1207 - 1213.
[Abstract] [Full Text]

Home page
 BloodHome page
A. Sawano, S. Iwai, Y. Sakurai, M. Ito, K. Shitara, T. Nakahata, and M. Shibuya
Flt-1, vascular endothelial growth factor receptor 1, is a novel cell surface marker for the lineage of monocyte-macrophages in humans
Blood, February 1, 2001; 97(3): 785 - 791.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
E. Tanaka, N. Hattan, K. Ando, H. Ueno, Y. Sugio, M. U. Mohammed, S. A. Voltchikhina, and H. Mori
Amelioration of microvascular myocardial ischemia by gene transfer of vascular endothelial growth factor in rabbits
J. Thorac. Cardiovasc. Surg., October 1, 2000; 120(4): 720 - 728.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
R. A. Brekken, J. P. Overholser, V. A. Stastny, J. Waltenberger, J. D. Minna, and P. E. Thorpe
Selective Inhibition of Vascular Endothelial Growth Factor (VEGF) Receptor 2 (KDR/Flk-1) Activity by a Monoclonal Anti-VEGF Antibody Blocks Tumor Growth in Mice
Cancer Res., September 1, 2000; 60(18): 5117 - 5124.
[Abstract] [Full Text]

Home page
 BloodHome page
F. Vidal, J. Aragones, A. Alfranca, and M. O. de Landazuri
Up-regulation of vascular endothelial growth factor receptor Flt-1 after endothelial denudation: role of transcription factor Egr-1
Blood, June 1, 2000; 95(11): 3387 - 3395.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D.-Q. Guo, L.-W. Wu, J. D. Dunbar, O. N. Ozes, L. D. Mayo, K. M. Kessler, J. A. Gustin, M. R. Baerwald, E. A. Jaffe, R. S. Warren, et al.
Tumor Necrosis Factor Employs a Protein-tyrosine Phosphatase to Inhibit Activation of KDR and Vascular Endothelial Cell Growth Factor-induced Endothelial Cell Proliferation
J. Biol. Chem., April 6, 2000; 275(15): 11216 - 11221.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. Takayama, H. Ueno, Y. Nakanishi, T. Sakamoto, K. Inoue, K. Shimizu, H. Oohashi, and N. Hara
Suppression of Tumor Angiogenesis and Growth by Gene Transfer of a Soluble Form of Vascular Endothelial Growth Factor Receptor into a Remote Organ
Cancer Res., April 1, 2000; 60(8): 2169 - 2177.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
L.-W. Wu, L. D. Mayo, J. D. Dunbar, K. M. Kessler, M. R. Baerwald, E. A. Jaffe, D. Wang, R. S. Warren, and D. B. Donner
Utilization of Distinct Signaling Pathways by Receptors for Vascular Endothelial Cell Growth Factor and Other Mitogens in the Induction of Endothelial Cell Proliferation
J. Biol. Chem., February 18, 2000; 275(7): 5096 - 5103.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
T. Veikkola, M. Karkkainen, L. Claesson-Welsh, and K. Alitalo
Regulation of Angiogenesis via Vascular Endothelial Growth Factor Receptors
Cancer Res., January 1, 2000; 60(2): 203 - 212.
[Full Text]

Home page
 JEMHome page
S. Niida, M. Kaku, H. Amano, H. Yoshida, H. Kataoka, S. Nishikawa, K. Tanne, N. Maeda, S.-I. Nishikawa, and H. Kodama
Vascular Endothelial Growth Factor Can Substitute for Macrophage Colony-stimulating Factor in the Support of Osteoclastic Bone Resorption
J. Exp. Med., July 19, 1999; 190(2): 293 - 298.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. A. Cunningham, T. M. Tran, M. P. Arrate, and T. A. Brock
Characterization of Vascular Endothelial Cell Growth Factor Interactions with the Kinase Insert Domain-containing Receptor Tyrosine Kinase. A REAL TIME KINETIC STUDY
J. Biol. Chem., June 25, 1999; 274(26): 18421 - 18427.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
R. Valtola, P. Salven, P. Heikkila, J. Taipale, H. Joensuu, M. Rehn, T. Pihlajaniemi, H. Weich, R. deWaal, and K. Alitalo
VEGFR-3 and Its Ligand VEGF-C Are Associated with Angiogenesis in Breast Cancer
Am. J. Pathol., May 1, 1999; 154(5): 1381 - 1390.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
J. Desai, V. Holt-Shore, R. J. Torry, M. R. Caudle, and D. S. Torry
Signal Transduction and Biological Function of Placenta Growth Factor in Primary Human Trophoblast
Biol Reprod, April 1, 1999; 60(4): 887 - 892.
[Abstract] [Full Text]

Home page
 Br. J. Ophthalmol.Home page
G. Smith, D. McLeod, D. Foreman, and M. Boulton
Immunolocalisation of the VEGF receptors FLT-1, KDR, and FLT-4 in diabetic retinopathy
Br. J. Ophthalmol., April 1, 1999; 83(4): 486 - 494.
[Abstract] [Full Text]

Home page
 Am. J. Physiol. Cell Physiol.Home page
S. A. Cunningham, T. M. Tran, M. P. Arrate, R. Bjercke, and T. A. Brock
KDR activation is crucial for VEGF165-mediated Ca2+ mobilization in human umbilical vein endothelial cells
Am J Physiol Cell Physiol, January 1, 1999; 276(1): C176 - C181.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Ogawa, A. Oku, A. Sawano, S. Yamaguchi, Y. Yazaki, and M. Shibuya
A Novel Type of Vascular Endothelial Growth Factor, VEGF-E (NZ-7 VEGF), Preferentially Utilizes KDR/Flk-1 Receptor and Carries a Potent Mitotic Activity without Heparin-binding Domain
J. Biol. Chem., November 20, 1998; 273(47): 31273 - 31282.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Shinkai, M. Ito, H. Anazawa, S. Yamaguchi, K. Shitara, and M. Shibuya
Mapping of the Sites Involved in Ligand Association and Dissociation at the Extracellular Domain of the Kinase Insert Domain-containing Receptor for Vascular Endothelial Growth Factor
J. Biol. Chem., November 20, 1998; 273(47): 31283 - 31288.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
B.-Q. Shen, D. Y. Lee, H.-P. Gerber, B. A. Keyt, N. Ferrara, and T. F. Zioncheck
Homologous Up-regulation of KDR/Flk-1 Receptor Expression by Vascular Endothelial Growth Factor in Vitro
J. Biol. Chem., November 6, 1998; 273(45): 29979 - 29985.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
D. J. Dumont, L. Jussila, J. Taipale, A. Lymboussaki, T. Mustonen, K. Pajusola, M. Breitman, and K. Alitalo
Cardiovascular Failure in Mouse Embryos Deficient in VEGF Receptor-3
Science, October 30, 1998; 282(5390): 946 - 949.
[Abstract] [Full Text]

Home page
 Proc. Natl. Acad. Sci. USAHome page
B. Olofsson, E. Korpelainen, M. S. Pepper, S. J. Mandriota, K. Aase, V. Kumar, Y. Gunji, M. M. Jeltsch, M. Shibuya, K. Alitalo, et al.
Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells
PNAS, September 29, 1998; 95(20): 11709 - 11714.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Migdal, B. Huppertz, S. Tessler, A. Comforti, M. Shibuya, R. Reich, H. Baumann, and G. Neufeld
Neuropilin-1 Is a Placenta Growth Factor-2 Receptor
J. Biol. Chem., August 28, 1998; 273(35): 22272 - 22278.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S. Hiratsuka, O. Minowa, J. Kuno, T. Noda, and M. Shibuya
Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice
PNAS, August 4, 1998; 95(16): 9349 - 9354.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. Oyama, S. Ran, T. Ishida, S. Nadaf, L. Kerr, D. P. Carbone, and D. I. Gabrilovich
Vascular Endothelial Growth Factor Affects Dendritic Cell Maturation Through the Inhibition of Nuclear Factor-{kappa}B Activation in Hemopoietic Progenitor Cells
J. Immunol., February 1, 1998; 160(3): 1224 - 1232.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
T. Murohara, J. R. Horowitz, M. Silver, Y. Tsurumi, D. Chen, A. Sullivan, and J. M. Isner
Vascular Endothelial Growth Factor/Vascular Permeability Factor Enhances Vascular Permeability Via Nitric Oxide and Prostacyclin
Circulation, January 13, 1998; 97(1): 99 - 107.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
B. Barleon, F. Totzke, C. Herzog, S. Blanke, E. Kremmer, G. Siemeister, D. Marme, and G. Martiny-Baron
Mapping of the Sites for Ligand Binding and Receptor Dimerization at the Extracellular Domain of the Vascular Endothelial Growth Factor Receptor FLT-1
J. Biol. Chem., April 18, 1997; 272(16): 10382 - 10388.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
N. Rahimi, V. Dayanir, and K. Lashkari
Receptor Chimeras Indicate That the Vascular Endothelial Growth Factor Receptor-1 (VEGFR-1) Modulates Mitogenic Activity of VEGFR-2 in Endothelial Cells
J. Biol. Chem., May 26, 2000; 275(22): 16986 - 16992.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. Wang, D. B. Donner, and R. S. Warren
Homeostatic Modulation of Cell Surface KDR and Flt1 Expression and Expression of the Vascular Endothelial Cell Growth Factor (VEGF) Receptor mRNAs by VEGF
J. Biol. Chem., May 19, 2000; 275(21): 15905 - 15911.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
B. Li, G. Fuh, G. Meng, X. Xin, M. E. Gerritsen, B. Cunningham, and A. M. de Vos
Receptor-selective Variants of Human Vascular Endothelial Growth Factor. GENERATION AND CHARACTERIZATION
J. Biol. Chem., September 15, 2000; 275(38): 29823 - 29828.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. Suzuma, K. Naruse, I. Suzuma, N. Takahara, K. Ueki, L. P. Aiello, and G. L. King
Vascular Endothelial Growth Factor Induces Expression of Connective Tissue Growth Factor via KDR, Flt1, and Phosphatidylinositol 3-Kinase-Akt-dependent Pathways in Retinal Vascular Cells
J. Biol. Chem., December 22, 2000; 275(52): 40725 - 40731.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
B.-Q. Shen, D. Y. Lee, K. M. Cortopassi, L. A. Damico, and T. F. Zioncheck
Vascular Endothelial Growth Factor KDR Receptor Signaling Potentiates Tumor Necrosis Factor-induced Tissue Factor Expression in Endothelial Cells
J. Biol. Chem., February 9, 2001; 276(7): 5281 - 5286.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Iyer, D. D. Leonidas, G. J. Swaminathan, D. Maglione, M. Battisti, M. Tucci, M. G. Persico, and K. R. Acharya
The Crystal Structure of Human Placenta Growth Factor-1 (PlGF-1), an Angiogenic Protein, at 2.0 A Resolution
J. Biol. Chem., April 6, 2001; 276(15): 12153 - 12161.
[Abstract] [Full Text] [PDF]

Home page